India vildagliptin market is expected to grow at a steady rate during the forecast period, owing to the increasing diabetic population in the country. Additionally, supportive government policies and improving healthcare infrastructure are also expected to create lucrative opportunities for the market growth over the next few years. Furthermore, initiatives taken by physicians to minimize the costly burden of diabetic complications using combination therapies and novel branded drugs are further expected to rev up the market growth through FY2026.
The India vildagliptin market is segmented based on composition, source, strength, distribution channel, application, company and region. Based on source, the market can be split into in-house and contract manufacturing organizations. Out of which, the in-house segment dominated the market until FY2020 owing to in-house production preference by the major market players. The contract manufacturing organizations segment is expected to witness significant growth during the forecast period on account of an upsurge in the number of contract manufacturers in the country and increased outsourcing activities by the major companies in order to focus on their R&D activity and expansion plans. Additionally, contract manufacturing organizations offer competitive pricing and can provide bulk orders in a short duration. This is further projected to contribute to the segmental growth in the coming years.
The major players operating in the India vildagliptin market are Abbott India Limited, Torrent Pharmaceuticals Limited, Intas Pharmaceuticals Limited, Dr. Reddy’s Laboratories Ltd., IPCA Laboratories Ltd., Lupin Limited, Piramal Enterprises Ltd. (Piramal Pharma), Novartis India Limited, Cipla Ltd., Alembic Pharmaceuticals Ltd and others. Major companies are developing advanced technologies, receiving approvals from regulatory bodies and launching new products in order to stay competitive in the market. Other competitive strategies include mergers and acquisitions and new product developments.
Years considered for this report
Historical YearsFY2016-FY2019
Base YearFY2020
Estimated YearFY2021
Forecast PeriodFY2022–FY2026
Objective of the Study
- To analyze the historical growth in the market size of India vildagliptin market from FY2016 to FY2020.
- To estimate and forecast the market size of India vildagliptin market from FY2021 to FY2026 and growth rate until FY2026.
- To classify and forecast India vildagliptin market based on composition, source, strength, distribution channel, application, company and regional distribution.
- To identify dominant region or segment in the India vildagliptin market.
- To identify drivers and challenges for the India vildagliptin market.
- To examine competitive developments such as expansions, new product launches, and mergers & acquisitions in India vildagliptin market.
- To identify and analyze the profile of leading players operating in the India vildagliptin market.
- To identify key sustainable strategies adopted by market players in the India vildagliptin market.
Click here to download the sample
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.
Key Target Audience
- Vildagliptin manufacturers/ suppliers/ distributors
- Market research and consulting firms
- Government bodies such as regulating authorities and policy makers
- Organizations, forums and alliances related to vildagliptin
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
